Protagenic Therapeutics Inc (NASDAQ:PTIX)

0.63
Delayed Data
As of Sep 27
 0.00 / 0.00%
Today’s Change
0.56
Today|||52-Week Range
2.35
-54.51%
Year-to-Date

Stock Price Forecast

The 1 analysts offering 12-month price forecasts for Protagenic Therapeutics Inc have a median target of 4.00, with a high estimate of 4.00 and a low estimate of 4.00. The median estimate represents a +534.92% increase from the last price of 0.63.

Chart unavailable

Analyst Recommendations

The current consensus among 1 polled investment analysts is to Buy stock in Protagenic Therapeutics Inc. This rating has held steady since October, when it was unchanged from a Buy rating.Move your mouse over past
months for detail

 

Earnings and Sales Forecasts

Current Quarter

Earnings per Share
-$0.05
Sales
--
Reporting Date
Apr 07

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly 0.00%
 
 
 
 
 
Growthannually -45.16%
 
 
 
 
 
 

Sales

Growthquarterly --
 
 
 
 
Growthannually --
 
 
 
 
Key to the earnings and sales forecast charts.